Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • GerryB
    Member
    • May 2009
    • 12

    #1

    Alignment/assembly programs - Patent minefield

    There are many programs to align short reads to a reference, and quite a few denovo assemblers as well. The terrific list here gives great links to many tools.

    But when I see these nifty toys and pick them up to examine them, it's clear that there's a quietly deadly dangers in many, in fact probably all, of the tools.

    Which of these tools are safe to use without fear of patent violations? From my experience in database tools, the patent mindfield is terrible. But it seems even worse in bioinformatics because the field is newer and therefore more of the basic infrastructure has been patented from the start.



    The Celera assembler for example, is covered by multiple patents and it's clearly not legal to use their methods, even for academic non-profit use. The GPL license is not what I'm talking about, but the patents underlaying its function. I'm not saying people haven't used the assember, but that their use is likely a violation even if Celera hasn't persued it yet. Celera is also far from the only patent holder.

    This applies to almost all of these tools. I doubt any one of them is free from patent restrictions. Even the awesome and elegant Bowtie is likely infringing multiple times, since about anything that uses the BWT to search on DNA sequences is patented.

    How are people protecting themselves from this issue? Have patent holders like Celera offered licenses, or indemity, at least for noncommercial users?
    How do the researchers of these algorithms defend themselves?

    How could any company even think to commercialize such tools unless they have a huge portfolio of patents of their own to play mutual-assured-destruction faceoffs with?

    I fear that the answers to these questions is that people have just ignored the issues for now and hope that none of the patent holders decides to start poking at their projects.
  • jkbonfield
    Senior Member
    • Jul 2008
    • 146

    #2
    There's no doubt that this is a mine field, however the BWT based aligners could argue they're based primarily on the fm-index papers (which predate these patents) rather than the specific tweaks employed in these patents.

    A complex mess though, and one which only serves to demonstrate why software patents are generally bad for science as a whole.

    Comment

    • lry198010
      Member
      • Aug 2008
      • 13

      #3
      I think it's really the issue when the analysis tool such as BWT are necessary in the personal genome era.

      Comment

      • mchaisso
        Member
        • Apr 2008
        • 84

        #4
        IANAL, but unless one has a method that is not based on published papers, a better business model may be the service model, rather than patent and protect.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        35 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...